Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)

被引：5
|
作者：
Grützmacher P. [1 ]
Öhm B. [1 ]
Szymczak S. [1 ]
Dorbath C. [1 ]
Brzoska M. [1 ]
Kleinert C. [1 ]
机构：
[1] 2nd Medical Clinic – Nephrology, Hypertension and Vascular Diseases, AGAPLESION Markus-Hospital, Frankfurt/Main
来源：
Clinical Research in Cardiology Supplements | 2017年 / 12卷 / Suppl 1期
关键词：
Cardiovascular prevention; Lipoprotein (a); Lp (a) apheresis; Target LDL cholesterol;
D O I：
10.1007/s11789-017-0090-3
中图分类号：
学科分类号：
摘要：
General lipoprotein (Lp) (a) screening can help to identify patients at high risk for cardiovascular disease. Non-invasive methods allow early detection of clinically asymptomatic incipient atherosclerotic disease. Medical treatment options are still unsatisfactory. Lp(a) apheresis is an established treatment in Germany for secondary prevention of progressive cardiovascular disease. Statin-based lowering of LDL cholesterol and thrombocyte aggregation inhibitors still represent the basis of medical treatment. Target levels for LDL-cholesterol should be modified in patients with hyperlipoproteinemia (a). © 2017, The Author(s).
引用
收藏
页码：22 / 26
页数：4
相关论文
共 50 条
  • [21] Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
    Abdelhamid, Asmaa S.
    Martin, Nicole
    Bridges, Charlene
    Brainard, Julii S.
    Wang, Xia
    Brown, Tracey J.
    Hanson, Sarah
    Jimoh, Oluseyi F.
    Ajabnoor, Sarah M.
    Deane, Katherine H. O.
    Song, Fujian
    Hooper, Lee
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (07):
  • [22] A SYMPOSIUM - PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR-DISEASE - INTRODUCTION
    FRISHMAN, WH
    TAYLOR, SH
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (09): : C1 - C2
  • [23] Value of physical activity in primary and secondary prevention of cardiovascular disease
    Linke, A.
    Hambrecht, R.
    [J]. KARDIOLOGE, 2008, 2 (01): : 17 - 27
  • [24] A telemonitoring program for screening and primary and secondary prevention of cardiovascular disease
    Lupi, L.
    Glisenti, F.
    Papa, I.
    Arabia, G.
    Piazzani, M.
    Fabbricatore, D.
    Castiello, A.
    Madureri, A.
    Nodari, S.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 860 - 860
  • [25] Secondary prevention of cardiovascular disease: in a hospital environment or in primary care?
    Rubies-Prat, Juan
    [J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2006, 18 (04): : 137 - 138
  • [26] Atherosclerotic Cardiovascular Disease Primary and Secondary Prevention in Latino Subgroups
    Kaufmann, Jorge
    Marino, Miguel
    Lucas, Jennifer A.
    Rodriguez, Carlos J.
    Boston, Dave
    Giebultowicz, Sophia
    Heintzman, John
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (11) : 2041 - 2050
  • [27] A SYMPOSIUM - PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR-DISEASE - CONCLUSIONS
    TAYLOR, SH
    FRISHMAN, WH
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (09): : C55 - C55
  • [28] Sex Differences in Primary and Secondary Prevention of Cardiovascular Disease in China
    Xia, Shijun
    Du, Xin
    Guo, Lizhu
    Du, Jing
    Arnott, Clare
    Lam, Carolyn S. P.
    Huffman, Mark D.
    Arima, Hisatomi
    Yuan, Yiqiang
    Zheng, Yang
    Wu, Shulin
    Guang, Xuefeng
    Zhou, Xianhui
    Lin, Hongbo
    Cheng, Xiaoshu
    Anderson, Craig S.
    Dong, Jianzeng
    Ma, Changsheng
    [J]. CIRCULATION, 2020, 141 (07) : 530 - 539
  • [29] Primary and Secondary Prevention Strategy for Cardiovascular Disease in Diabetes Mellitus
    Srikanth, Sundararajan
    Deedwania, Prakash
    [J]. CARDIOLOGY CLINICS, 2011, 29 (01) : 47 - +
  • [30] SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN PERIPHERAL ARTERY DISEASE PATIENTS
    Rashid, S. T.
    Bangee, S.
    [J]. BRITISH JOURNAL OF SURGERY, 2021, 108 : 31 - 31
12345